Endostatin gene variation and protein levels in breast cancer susceptibility and severity

BACKGROUND: Endostatin is a potent endogenous anti-angiogenic agent which inhibits tumour growth. A non-synonymous coding polymorphism in the Endostatin gene is thought to affect Endostatin activity. We aimed to determine the role of this Endostatin polymorphism in breast cancer pathogenesis and any...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramanian, Sabapathy P, Cross, Simon S, Globe, Jenny, Cox, Angela, Brown, Nicola J, Reed, Malcolm W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924861/
https://www.ncbi.nlm.nih.gov/pubmed/17587451
http://dx.doi.org/10.1186/1471-2407-7-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924861/
https://www.ncbi.nlm.nih.gov/pubmed/17587451
http://dx.doi.org/10.1186/1471-2407-7-107

Ejemplares similares